Brokerages Set Hinge Health Inc. (NYSE:HNGE) Price Target at $46.00

Shares of Hinge Health Inc. (NYSE:HNGE) have received an average rating of “Buy” from the thirteen analysts that are currently covering the company, MarketBeat reports. Thirteen analysts have rated the stock with a buy rating. The average twelve-month price target among brokerages that have covered the stock in the last year is $46.00.

Several equities analysts have recently issued reports on the stock. Stifel Nicolaus initiated coverage on shares of Hinge Health in a research note on Monday, June 16th. They issued a “buy” rating and a $48.00 price objective on the stock. Evercore ISI initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an “outperform” rating and a $50.00 target price on the stock. Morgan Stanley initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an “overweight” rating and a $46.00 target price on the stock. KeyCorp initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an “overweight” rating and a $45.00 target price on the stock. Finally, Raymond James Financial initiated coverage on shares of Hinge Health in a research report on Monday, June 16th. They issued an “outperform” rating and a $45.00 target price on the stock.

Hinge Health Trading Up 7.7%

Shares of HNGE opened at $47.56 on Friday. Hinge Health has a 12-month low of $33.42 and a 12-month high of $52.16.

Hinge Health Company Profile

Our vision is to build a new health system that transforms outcomes, experience and costs by using technology to scale and automate the delivery of care. Hinge Health leverages software, including AI, to largely automate care for joint and muscle health, delivering an outstanding member experience, improved member outcomes, and cost reductions for our clients.